| Drug Name |
Tetrabenazine |
| Drug ID |
BADD_D02175 |
| Description |
A drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders. It is a monoamine depletor and used as symptomatic treatment of chorea associated with Huntington's disease. FDA approved on August 15, 2008. |
| Indications and Usage |
Treatment of hyperkinetic movement disorders like chorea in Huntington's disease, hemiballismus, senile chorea, Tourette syndrome and other tic disorders, and tardive dyskinesia |
| Marketing Status |
Prescription |
| ATC Code |
N07XX06 |
| DrugBank ID |
DB04844
|
| KEGG ID |
D08575
|
| MeSH ID |
D013747
|
| PubChem ID |
6018
|
| TTD Drug ID |
D09PJX
|
| NDC Product Code |
0054-0469; 60505-3882; 51224-426; 43598-394; 27241-177; 42291-806; 51224-425; 65977-0085; 47335-277; 31722-822; 68180-408; 70436-102; 51407-481; 42291-807; 65085-0064; 65015-831; 0054-0468; 69452-117; 69766-076; 43598-395; 42973-179; 62756-871; 31722-821; 64330-066; 68180-409; 64567-0025; 68682-421; 63827-1013; 51407-480; 69452-118; 47335-179; 68682-422; 60505-3883; 70436-101; 27241-176 |
| Synonyms |
Tetrabenazine | Nitoman | Xenazine |
